New 1,3,4‐Thiadiazole‐Based Dual B‐Raf/VEGFR‐2 Inhibitors With Potential Anti‐Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations

Documenti analoghi

• Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities‏
  di: Hazem Elkady, et al.
  Pubblicazione: (2025)
• Exploring Novel Nitrofuryl‐1,3,4‐Thiadiazole‐Based Derivatives: Design, Synthesis, and Evaluation of In Vitro Leishmanicidal and Trypanocidal Activity
  di: Alireza Mousavi, et al.
  Pubblicazione: (2026)
• Design, Synthesis, Biological Evaluation, and In Silico Studies of Novel Furo[2,3‐ d ]pyrimidine Derivatives as EGFR Inhibitors With Potential Antitumor Activity
  di: Samar I. Faggal, et al.
  Pubblicazione: (2025)
• New Benzimidazole Scaffolds Tagged With Isatin/Thiourea Motifs as Anti‐Cancer Agents: Promising Approach for VEGFR‐2 Inhibition
  di: Alaa M. Ali, et al.
  Pubblicazione: (2026)
• Ultra‐Fast Green UPLC‐MS/MS Method for the Quantification of Cediranib in the Human Liver Microsome Matrix: In Vitro and In Silico Metabolic Stability Assessment
  di: Mohamed W. Attwa, et al.
  Pubblicazione: (2025)